I don't know the timeline, but at the AGM I think it was Ken Taylor who when asked about DIABECELL said that DOL had spent "scores of millions probably more" on refining the product in readiness for an FDA application, now I can't recall if that application has been made already. This kind of progess surely should have been communicated to the market, if LCT had any interest in their SP.
